Inventor

ELZEIN ELFATIH

US73 patents

⚠️ This page may combine multiple inventors who share the name “ELZEIN ELFATIH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ELZEIN ELFATIH

CV THERAPEUTICS INC

A2B adenosine receptor antagonists

A2B adenosine receptor antagonists

Heteroaryl alkyl piperazine derivatives

Aralkyl substituted piperazine compounds

Substituted piperazine compounds

A2B adenosine receptor antagonists

A2B adenosine receptor antagonists

A2B adenosine receptor antagonists

Partial and full agonists of A1 adenosine receptors

Substituted alkyl piperazine derivatives

A2B adenosine receptor antagonists

Partial and full agonists A1 adenosine receptors

Substituted piperazine compounds

A1 adenosine receptor agonists

A2B adenosine receptor antagonists

Partial and full agonists of A1 adenosine receptors

Substituted heterocyclic compounds

A1 adenosine receptor agonists

Substituted heterocyclic compounds

A1 adenosine receptor agonists

Adenosine A3 receptor agonists

Partial and full agonists of A1 adenosine receptors

Partial and full agonists of A1 adenosine receptors

Substituted pyrrolo[3,2-d]pyrimidin-2,4-diones as A2b adenosine receptor antagonists

GILEAD SCIENCES INC

Fused heterocyclic compounds as ion channel modulators

Process for preparing an A2A-adenosine receptor agonist and its polymorphs

Fused heterocyclic compounds as ion channel modulators

Fused heterocyclic compounds as ion channel modulators

Fused heterocyclic compounds as ion channel modulators

Process for preparing an A2A-adenosine receptor agonist and its polymorphs

Fused heterocyclic compounds as ion channel modulators

Process for preparing an A2A-adenosine receptor agonist and its polymorphs

Therapeutic heterocyclic compounds

GILEAD PALO ALTO INC

Process for preparing an A2A-adenosine receptor agonist and its polymorphs

Process for preparing an A2A-adenosine receptor agonist and its polymorphs

A2B adenosine receptor antagonists

Prodrugs of A2B adenosine receptor antagonists

A2B adenosine receptor antagonists

Partial and full agonists of A1 adenosine receptors

ZABLOCKI JEFF

Process for preparing an A2A-adenosine receptor agonist and its polymorphs

Monohydrate of (1-{9-[4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminopurin-2-yl}pyrazol-4-yl)-N-methylcarboxamide

Process for preparing an A2A-adenosine receptor agonist and its polymorphs

ALDH-2 inhibitors in the treatment of addiction

CORKEY BRITTON KENNETH

Fused heterocyclic compounds as ion channel modulators

Fused heterocyclic compounds as ion channel modulators

Fused heterocyclic compounds as ion channel modulators

CORKEY BRITTON

Fused heterocyclic compounds as ion channel modulators

Fused heterocyclic compounds as ion channel modulators

ABELMAN MATTHEW

Fused heterocyclic compounds as ion channel modulators

KALLA RAO

A2B adenosine receptor antagonists